Cefotetan

This classification denotes a cephalosporin antibiotic with the molecular formula C17H17N7O8S4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 48SPP0PA9Q, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6alpha,7alpha))- but generally known as cefotetan, which bears US NIH Compound Identifier 50614. European Medicines Agency schedules Cefotetan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07406MIG. The term CEFOTETAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules cefotetan in its Anatomical Therapeutic Chemical (ATC) Classification. CEFOTETAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cefotetan under HS 29419000 and SITC 54139. As of Q4 2014, CEFOTETAN remains the US FDA Preferred Term for this commodity. Cefotetan bears US NLM identifiers UMLS ID C0007555 and NCI Concept Code C61664. SMILES: S1C2N(C(=O)C2(OC)NC(=O)C2S/C(=C(/C(=O)N)C(=O)O)S2)C(=C(C1)CSC1N(NNN1)C)C(=O)O.